학술논문

Recurrent squamous cell carcinoma of the skin treated with immunotherapy.
Document Type
Case Study
Source
Journal of Cancer Research & Therapeutics. 2022 Suppl 2, Vol. 18, p495-497. 3p.
Subject
*SQUAMOUS cell carcinoma
*IMMUNOTHERAPY
*HIV
*METASTASIS
*SKIN diseases
Language
ISSN
0973-1482
Abstract
Squamous cell carcinoma (SCC) has a good prognosis, while metastatic tumors have aggressive behavior. Immunotherapy has become a standard line of treatment in metastatic cancers; pembrolizumab has shown promising results and improved quality of life in recurrent and metastatic cancers. We report a case of recurrent SCC of the skin with extensive disease and a known case of human immunodeficiency virus. He completed standard lines of treatment and currently on immunotherapy. After 3 cycles of immunotherapy plus chemotherapy, he got a complete metabolic response. Our experience showed palliative benefits and increased quality of life. [ABSTRACT FROM AUTHOR]